Erleada for treating prostate cancer

The U.S. Food and Drug Administration (FDA) has approved Erleada (apalutamide), a next-generation androgen receptor inhibitor for the treatment of patients with non-metastatic castration-resistant prostate cancer. Erleada is a prescription medicine used to treat prostate cancer that has not spread to other parts of the body and no longer responds to a medical or surgical treatment that lowers testosterone.

Before you start treatment, tell your healthcare provider about all your medical conditions, including if you have a history of seizures, brain injury, stroke, or brain tumors. If you have a partner who is pregnant or may become pregnant. Men who are sexually active with a pregnant woman must use a condom during and for three months after treatment.

Erleada treatment can cause bones and muscles to weaken and may increase risk for falls and fractures. Falls and fractures have happened in people during treatment with Erleada. Falls were not caused by loss of consciousness (fainting) or seizures. Your healthcare provider will monitor your risks for falls and fractures during treatment.

Seizure-if you take Erleada, you may be at risk of having a seizure. You should avoid activities where a sudden loss of consciousness could cause serious harm. Tell your healthcare provider right away if you have a loss of consciousness or seizure. Your healthcare provider will stop Erleada if you have a seizure during treatment.

The most common side effects include:feeling very tired, high blood pressure, rash, diarrhea, nausea, decreased appetite, weight loss, joint pain, fall, hot flash, bone injury (fracture), swollen hands, ankles and feet. Erleada may cause fertility problems.
          haleplushearty.blogspot.com

Blood sugar monitor without finger pricks

U.S. regulators have approved the first continuous blood sugar monitor for diabetics that doesn't need backup finger prick tests. Current models require users to test a drop of blood twice daily to calibrate, or adjust, the monitor.

The pain of finger sticks and the cost of testing supplies discourage many people from keeping close tabs on their blood sugar, which is needed to manage insulin use and adjust what they eat.

The Food and Drug Administration has approved the device, which continuously monitors diabetics' blood sugar levels without requiring backup finger prick tests. Current models require users to test a drop of blood twice daily to calibrate, or adjust, the monitor.

Too-high blood sugar levels can damage organs and lead to heart attacks, strokes, blindness and amputations. Very low blood sugar can cause seizures, confusion and loss of consciousness.

The device was approved for adults with Type 1 or Type 2 diabetes, this device cannot be used with an insulin pump, a device worn against the skin that allows users to inject insulin as needed, but the company is planning improvements to eventually enable that.
          haleplushearty.blogspot.com

Symptoms of metastatic breast cancer

Metastatic breast cancer is an advanced cancer that has spread to other organs in the body, if initial cancer treatments failed it can result into stage 4 cancer which can spread to brain, bones, lungs and liver.

Symptoms of the spread to bones are: pain, fractures, swelling and spinal cord compression.

Symptoms of the spread to liver are: loss of appetite, vomiting, nausea, bleeding, skin rash and pain.

Symptoms of the spread to brain are: headache, seizure, blurred vision, irrational behavior and nausea.

If it spreads to lungs it can cause chest pain, coughing of blood and shortness of breath.

Treatment
Systemic therapy or medication like chemotherapy and hormone therapy are required for treating metastatic cancer.